Detalles de la búsqueda
1.
Doubtful use of placebo following placebo in recent controlled trials of lasmiditan and ubrogepant for the treatment of migraine attacks.
Cephalalgia
; 42(1): 82-85, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407653
2.
Naratriptan is as effective as sumatriptan for the treatment of migraine attacks when used properly. A mini-review.
Cephalalgia
; 41(14): 1499-1505, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34275352
3.
Onset of action in placebo-controlled migraine attacks trials: A literature review and recommendation.
Cephalalgia
; 41(2): 148-155, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32903063
4.
Erenumab prevents the occurrence of migraine attacks and not just migraine days: Post-hoc analyses of a phase III study.
Cephalalgia
; 41(11-12): 1262-1267, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33939497
5.
Pain freedom after 2 hours should be the primary outcome in controlled trials treating migraine attacks.
Cephalalgia
; 40(12): 1331-1335, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32660268
6.
Problematic presentation and use of efficacy measures in current trials of CGRP monoclonal antibodies for episodic migraine prevention: A mini-review.
Cephalalgia
; 40(1): 122-126, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31547694
7.
Why is the therapeutic effect of acute antimigraine drugs delayed? A review of controlled trials and hypotheses about the delay of effect.
Br J Clin Pharmacol
; 85(11): 2487-2498, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31389059
8.
Evaluating the reporting of adverse events in controlled clinical trials conducted in 2010-2015 on migraine drug treatments.
Cephalalgia
; 38(12): 1885-1895, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29448820
9.
Delayed absorption of many (paracetamol, aspirin, other NSAIDs and zolmitriptan) but not all (sumatriptan, rizatriptan) drugs during migraine attacks and most likely normal gastric emptying outside attacks. A review.
Cephalalgia
; 37(9): 892-901, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27330004
10.
General lack of use of placebo in prophylactic, randomised, controlled trials in adult migraine. A systematic review.
Cephalalgia
; 36(10): 960-9, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26553731
11.
Critique of the analysis of the time course for the antimigraine effect of ubrogepant 50 mg. Clinical relevance versus statistical significance.
Cephalalgia
; 41(11-12): 1276-1278, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33982622
12.
The Evidence for Prescription Information for Possible Use of a Repeated Dose of Oral Triptans: A Comment.
Headache
; 56(5): 878-882, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27040157
13.
Is the Generally Held View That Intravenous Dihydroergotamine Is Effective in Migraine Based on Wrong "General Consensus" of One Trial? A Critical Review of the Trial and Subsequent Quotations.
Headache
; 56(9): 1482-1491, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27595607
14.
What efficacy measures are clinically relevant and should be used in Cochrane Reviews of acute migraine trials? A viewpoint.
Cephalalgia
; 35(5): 457-9, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25135653
15.
The qualitative problem of major quotation errors, as illustrated by 10 different examples in the headache literature.
Headache
; 55(3): 419-26, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25760466
16.
Further Questioning of the Significance of the Gepants: A Response.
Headache
; 59(10): 1831, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31710110
17.
Misused and Misleading: "100% Response Rate" to Galcanezumab in Patients With Episodic Migraine.
Headache
; 59(4): 626, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30973199
18.
The Emperor's New Gepants: Are the Effects of the New Oral CGRP Antagonists Clinically Meaningful?
Headache
; 59(1): 113-117, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30451300
19.
The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells.
Fluids Barriers CNS
; 21(1): 39, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38711118
20.
Relatively slow and long-lasting antimigraine effect of dihydroergotamine is most likely due to basic pharmacological attributes of the drug: a review.
Cephalalgia
; 33(13): 1122-31, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23588793